Erste Asset Management’s MacroGenics MGNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-18,000
Closed -$286K 566
2021
Q4
$286K Hold
18,000
0.01% 474
2021
Q3
$369K Hold
18,000
0.01% 442
2021
Q2
$481K Hold
18,000
0.01% 417
2021
Q1
$560K Hold
18,000
0.01% 381
2020
Q4
$411K Buy
+18,000
New +$414K 0.01% 404
2019
Q3
Sell
-11,400
Closed -$190K 432
2019
Q2
$190K Hold
11,400
0.01% 367
2019
Q1
$200K Hold
11,400
0.01% 357
2018
Q4
$144K Buy
+11,400
New +$191K 0.01% 380

Other funds holding MGNX

Erste Asset Management's MGNX Position: Q1 2022 in Review

Erste Asset Management sold out of MacroGenics (MGNX) in Q1 2022, closing a stake of 18,000 shares — an estimated $286K sold.

Erste Asset Management first reported a position in MGNX in Q4 2018 and held it in 8 quarters. The position peaked at $560K in Q1 2021. 144 funds tracked by Wall St. Rank hold MGNX as of Q1 2022.

  • Erste Asset Management reported no remaining MacroGenics position as of Q1 2022 after selling out during the quarter.
  • Erste Asset Management sold 18,000 MacroGenics shares in Q1 2022, an estimated $286K.
  • Erste Asset Management first reported a position in MacroGenics in Q4 2018 and held it in 8 quarters.
  • Erste Asset Management's MacroGenics position peaked at $560K in Q1 2021.
  • 144 funds tracked by Wall St. Rank held MacroGenics as of Q1 2022.

Based on Erste Asset Management's 13F filing for Q1 2022, filed 25 Nov 2024.